Pacific Biosciences of California Inc (STU:P09)
€ 2.319 0.068 (3.02%) Market Cap: 639.11 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.39 GF Score: 57/100

Pacific Biosciences of California Inc at JPMorgan Healthcare Conference- Panel Transcript

Jan 11, 2023 / 01:15AM GMT
Release Date Price: €9.14 (+1.22%)
Ruizhi Qin
JPMorgan Chase & Co, Research Division - Analyst

All right. Let's get started. Welcome to day 3 afternoon of the JPMorgan Healthcare Conference. I'm Julia Qin, lead analyst covering life science, tools and diagnostics at JPMorgan. And it's my great pleasure to introduce you to our next company presentation by PacBio. And with that, let me turn it over to Christian.

Christian O. Henry
Pacific Biosciences of California, Inc. - President, CEO & Director

All right. Thank you. Thank you, Julie, and thank you, JPMorgan, for hosting us. It's so great to see so many of you out in the audience, friends, for the first in-person JPM in a long time and my first as the CEO of PacBio. And so today, I've got a lot to share with you, so I'll try to go quickly.

But first, I'll start with the obligatory forward-looking statements, and there will be a test after. I had to keep it to one page. But please refer to our public filings if you have more information and more questions.

And with that, the mission of PacBio is really focused on

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot